|

68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer

RECRUITINGSponsored by Kunwei Shen
Actively Recruiting
SponsorKunwei Shen
Started2024-08-30
Est. completion2026-06-30
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06559371

Summary

The goal of this observational study is to learn whether 68Ga-FAPI PET/CT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is: Could 68Ga-FAPI PET/CT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET/CT test between last neoadjuvant therapy and surgery.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Female patients aged 18 and above
* ECOG score 0-2 points
* Pathological confirmation of malignant breast tumor
* Clinical axillary lymph node positivity (cN+)
* Completed at least 3 courses of neoadjuvant therapy and subjected to undergo surgical treatment
* Informed consent form signed

Exclusion Criteria:

* Distant metastasis
* Unable to complete the proposed neoadjuvant therapy plan
* Pregnancy

Conditions3

Breast CancerCancerPET-CT

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.